Home > News Center > Company News

Haohai Biological Technology Enters into Proposed List of “National Enterprise Technical Center”

Recently, the National Development and Reform Commission released the proposed (24th) list of 2017 National Enterprise Technical Centers, Haohai Biological Technology as the only biomedical enterprise in Shanghai has entered into the list and become the first biopharmaceutical company in Shanghai since 2015.

The list of “National Enterprise Technical Centers” was jointly reviewed and confirmed by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs, and the State Administration of Taxation. The accreditation of the first list was conducted in China in 1993. A total of 1,276 companies have been rated as national enterprise technology centers, including 61 Shanghai companies. There are 6 Shanghai pharmaceutical companies have entered into the list since the beginning, including Shanghai Leiyunshang Pharmaceutical Co., Ltd., Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai McroPort Medical Devices (Group) Co., Ltd., Shanghai AceBright Pharmaceutical Group Co., Ltd., Shanghai CITIC Guojian Pharmaceutical Co., Ltd., Shanghai WuXi App Tec New Drug Development Co., Ltd.

Haohai Biological Technology will be more determined on its road to innovation and entrepreneurship, committed to R&Ds of new technologies, new processes and new products with international leading levels and leading the industry to healthy and sustainable development.

News Center

Company News

Policy & Regulation

尊龙凯时·(中国区)公司官网首页

Haohai Biological Technology Enters into Proposed List of “National Enterprise Technical Center”